Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 69,695	$ 127,945
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	47,427	64,372
Amortization of deferred loan origination costs	16,739	18,968
Amortization of financing origination fees	2,999	2,194
Provision for long-term employee benefits	7,852	3,156
Employee benefit plan contributions and payments	(1,608)	(2,507)
Stock compensation expense	3,896	6,537
Net change in wholesale finance receivables related to sales	(208,183)	(237,569)
Provision for credit losses	79,419	34,491
Deferred income taxes	(3,803)	5,981
Other, net	3,579	2,731
Changes in current assets and liabilities:
Accounts receivable, net	(47,272)	(49,746)
Finance receivables – accrued interest and other	4,007	92
Inventories, net	(23,943)	(40,600)
Accounts payable and accrued liabilities	10,562	123,975
Derivative financial instruments	2,812	867
Other	27,240	(28,216)
Total adjustments	(78,277)	(95,274)
Net cash (used) provided by operating activities	(8,582)	32,671
Cash flows from investing activities:
Capital expenditures	(32,928)	(35,255)
Origination of finance receivables	(780,061)	(851,372)
Collections on finance receivables	841,261	815,824
Acquisition of business	0	(7,000)
Other investing activities	16	603
Net cash provided (used) by investing activities	28,288	(77,200)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	0	546,655
Repayments of medium-term notes	(600,000)	(750,000)
Proceeds from securitization debt	522,694	0
Repayments of securitization debt	(130,918)	(76,505)
Borrowings of asset-backed commercial paper	225,187	0
Repayments of asset-backed commercial paper	(67,809)	(72,401)
Net increase in unsecured commercial paper	772,208	58,527
Dividends paid	(58,817)	(60,859)
Repurchase of common stock	(7,071)	(61,712)
Issuance of common stock under share-based plans	34	616
Net cash provided (used) by financing activities	655,508	(415,679)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(5,732)	(409)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	905,366	1,259,748
Net increase (decrease) in cash, cash equivalents and restricted cash	669,482	(460,617)
Cash, cash equivalents and restricted cash, end of period	1,574,848	799,131
HDMC Entities
Cash flows from financing activities:
Proceeds from securitization debt	0
HDFS Entities
Cash flows from financing activities:
Proceeds from securitization debt	522,694
Reportable Legal Entities | HDMC Entities
Cash flows from operating activities:
Net income	152,426	129,414
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	45,383	62,187
Amortization of deferred loan origination costs	0	0
Amortization of financing origination fees	170	167
Provision for long-term employee benefits	7,852	3,156
Employee benefit plan contributions and payments	(1,608)	(2,507)
Stock compensation expense	2,915	5,845
Net change in wholesale finance receivables related to sales	0	0
Provision for credit losses	0	0
Deferred income taxes	5,137	6,195
Other, net	(2,247)	1,886
Changes in current assets and liabilities:
Accounts receivable, net	(189,527)	(243,734)
Finance receivables – accrued interest and other	0	0
Inventories, net	(23,943)	(40,600)
Accounts payable and accrued liabilities	32,736	122,462
Derivative financial instruments	2,779	834
Other	16,200	(41,339)
Total adjustments	(104,153)	(125,448)
Net cash (used) provided by operating activities	48,273	3,966
Cash flows from investing activities:
Capital expenditures	(32,275)	(34,657)
Origination of finance receivables	0	0
Collections on finance receivables	0	0
Acquisition of business		(7,000)
Other investing activities	16	603
Net cash provided (used) by investing activities	(32,259)	(41,054)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes		0
Repayments of medium-term notes	0	0
Repayments of securitization debt	0	0
Borrowings of asset-backed commercial paper	0
Repayments of asset-backed commercial paper	0	0
Net increase in unsecured commercial paper	0	0
Dividends paid	(58,817)	(60,859)
Repurchase of common stock	(7,071)	(61,712)
Issuance of common stock under share-based plans	34	616
Net cash provided (used) by financing activities	(65,854)	(121,955)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(5,295)	(1,115)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	470,649	544,548
Net increase (decrease) in cash, cash equivalents and restricted cash	(55,135)	(160,158)
Cash, cash equivalents and restricted cash, end of period	415,514	384,390
Reportable Legal Entities | HDFS Entities
Cash flows from operating activities:
Net income	16,955	43,453
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	2,044	2,185
Amortization of deferred loan origination costs	16,739	18,968
Amortization of financing origination fees	2,829	2,027
Provision for long-term employee benefits	0	0
Employee benefit plan contributions and payments	0	0
Stock compensation expense	981	692
Net change in wholesale finance receivables related to sales	0	0
Provision for credit losses	79,419	34,491
Deferred income taxes	(8,570)	314
Other, net	6,139	922
Changes in current assets and liabilities:
Accounts receivable, net	0	0
Finance receivables – accrued interest and other	4,007	92
Inventories, net	0	0
Accounts payable and accrued liabilities	122,438	180,980
Derivative financial instruments	33	33
Other	7,549	18,997
Total adjustments	233,608	259,701
Net cash (used) provided by operating activities	250,563	303,154
Cash flows from investing activities:
Capital expenditures	(653)	(598)
Origination of finance receivables	(1,598,240)	(1,691,416)
Collections on finance receivables	1,452,022	1,426,419
Acquisition of business		0
Other investing activities	0	0
Net cash provided (used) by investing activities	(146,871)	(265,595)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes		546,655
Repayments of medium-term notes	(600,000)	(750,000)
Repayments of securitization debt	(130,918)	(76,505)
Borrowings of asset-backed commercial paper	225,187
Repayments of asset-backed commercial paper	(67,809)	(72,401)
Net increase in unsecured commercial paper	772,208	58,527
Dividends paid	(100,000)	(45,000)
Repurchase of common stock	0	0
Issuance of common stock under share-based plans	0	0
Net cash provided (used) by financing activities	621,362	(338,724)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(437)	706
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	434,717	715,200
Net increase (decrease) in cash, cash equivalents and restricted cash	724,617	(300,459)
Cash, cash equivalents and restricted cash, end of period	1,159,334	414,741
Eliminations
Cash flows from operating activities:
Net income	(99,686)	(44,922)
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	0	0
Amortization of deferred loan origination costs	0	0
Amortization of financing origination fees	0	0
Provision for long-term employee benefits	0	0
Employee benefit plan contributions and payments	0	0
Stock compensation expense	0	0
Net change in wholesale finance receivables related to sales	(208,183)	(237,569)
Provision for credit losses	0	0
Deferred income taxes	(370)	(528)
Other, net	(313)	(77)
Changes in current assets and liabilities:
Accounts receivable, net	142,255	193,988
Finance receivables – accrued interest and other	0	0
Inventories, net	0	0
Accounts payable and accrued liabilities	(144,612)	(179,467)
Derivative financial instruments	0	0
Other	3,491	(5,874)
Total adjustments	(207,732)	(229,527)
Net cash (used) provided by operating activities	(307,418)	(274,449)
Cash flows from investing activities:
Capital expenditures	0	0
Origination of finance receivables	818,179	840,044
Collections on finance receivables	(610,761)	(610,595)
Acquisition of business		0
Other investing activities	0	0
Net cash provided (used) by investing activities	207,418	229,449
Cash flows from financing activities:
Proceeds from issuance of medium-term notes		0
Repayments of medium-term notes	0	0
Proceeds from securitization debt	0
Repayments of securitization debt	0	0
Borrowings of asset-backed commercial paper	0
Repayments of asset-backed commercial paper	0	0
Net increase in unsecured commercial paper	0	0
Dividends paid	100,000	45,000
Repurchase of common stock	0	0
Issuance of common stock under share-based plans	0	0
Net cash provided (used) by financing activities	100,000	45,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	0	0
Cash, cash equivalents and restricted cash, end of period	$ 0	$ 0